Income Taxes

6 Months Ended

Nov. 30, 2023

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

Note 21: Income Taxes

The following table summarizes the Company’s income tax accrued for the three and six and months ended November 30, 2023 and 2022:

The Company accounts for income taxes under FASB ASC 740-10, which provides for an asset and liability approach of accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized based on anticipated future tax consequences, using currently enacted tax laws, attributed to temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts calculated for income tax purposes.

The components of the income tax provision include:

	Three Months Ended November 30,
	2023			2022
Revenue	$	5,197,214		$	6,074,177
Directly attributable costs		(3,025,595	)		(3,613,744	)
Deferred		2,171,619			2,460,433
Tax rate		21	%		21	%
Tax expense	$	456,040		$	516,691

	Six Months Ended November 30,
	2023			2022
Revenue	$	10,311,741		$	12,119,104
Directly attributable costs		(5,866,196	)		(7,186,837	)
Deferred		4,445,545			4,932,267
Tax rate		21	%		21	%
Tax expense	$	933,564		$	1,035,776

Note: Change in uncertain tax position with all tax expense recorded in current year due to change in estimate. No prior year net operating loss was considered.

Due to the accrual of taxes related to Section 280E of the Internal Revenue Code, as amended, the Company has an uncertain tax accrual that is currently being expensed as a change in estimate. The Company has net operating losses that it believes are available to it to offset this expense; however, there can be no assurance under current interpretations of tax laws for cannabis companies that the Company will be allowed to use these net operating losses to offset Section 280E tax expenses.